Kidney Transplant Recipient
13
1
1
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.7%
1 terminated out of 13 trials
88.9%
+2.4% vs benchmark
15%
2 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (13)
Vascular Complications After Kidney Transplantation
Renal Ex Vivo SYN002 Perfusion to Eliminate CMV Transmission
Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients
Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus
Outcomes of a Pre-operative Exercise Programme for Live Donor and Recipient Kidney Transplant Patients
Subcutaneous Abatacept in Renal Transplant Recipients
Investigation of the Effects of Quadratus Lumborum Block Applied to Patients in Kidney Transplant Surgery
Televideo Exercise and Nutrition Program for Kidney Transplant Recipients
Clinical Significance of 64-slice Multidetector Coronary CT Angiography to Evaluate the Prevalence and Severity of Coronary Artery Disease in Renal Transplant Recipients
Pharmacokinetics of Mmf and Valganciclovir
Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies
Isoniazid (INH) Treatment Based on ELISPOT Assay
Chronotherapy Versus Conventional BP Control to Correct Abnormal Circadian BP Pattern in Kidney Transplant Recipients